The crosstalk between SUMOylation and immune system in host-pathogen interactions

References

• Afrasiabi S, Chiniforush N, Partoazar A, Goudarzi R. 2023. The role of bacterial infections in rheumatoid arthritis development and novel therapeutic interventions: focus on oral infections. J Clin Lab Anal. 37(8):e24897.doi:10.1002/jcla.24897.
   PubMed Web of Science ®Google Scholar
• Albrow VE, Ponder EL, Fasci D, Békés M, Deu E, Salvesen GS, Bogyo M. 2011. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases. Chem Biol. 18(6):722–732.doi:10.1016/j.chembiol.2011.05.008.
   PubMedGoogle Scholar
• Amprazi M, Tomatsidou A, Paliogianni D, Fadouloglou VE. 2021. Post-translational modifications: host defence mechanism, pathogenic weapon, and emerged target of anti-infective drugs. In Frontiers in Anti-Infective Drug Discovery, Edited by Atta-ur-Rahman and Muhammad Iqbal Choudhary, Vol. 9. Sharjah: Bentham Science; p. 25–122. doi:10.2174/9781681088297121090004.
   Google Scholar
• Aqdas M, Sung MH. 2023. NF-kappaB dynamics in the language of immune cells. Trends Immunol. 44(1):32–43.doi:10.1016/j.it.2022.11.005.
   PubMed Web of Science ®Google Scholar
• Baczyk D, Audette MC, Drewlo S, Levytska K, Kingdom JC. 2017. SUMO-4: a novel functional candidate in the human placental protein SUMOylation machinery. PLoS One. 12(5):e0178056.doi:10.1371/journal.pone.0178056.
   PubMed Web of Science ®Google Scholar
• Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative. 2022. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 400(10350):452–461.doi:10.1016/s0140-6736(22)01214-4.
   PubMed Web of Science ®Google Scholar
• Barry R, John SW, Liccardi G, Tenev T, Jaco I, Chen C-H, Choi J, Kasperkiewicz P, Fernandes-Alnemri T, Alnemri E, et al. 2018. SUMO-mediated regulation of NLRP3 modulates inflammasome activity. Nat Commun. 9(1):3001.doi:10.1038/s41467-018-05321-2.
   PubMedGoogle Scholar
• Bentz GL, Lowrey AJ, Horne DC, Nguyen V, Satterfield AR, Ross TD, Harrod AE, Uchakina ON, McKallip RJ. 2019. Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency. PLoS One. 14(5):e0217578.doi:10.1371/journal.pone.0217578.
   PubMed Web of Science ®Google Scholar
• Bentz GL, Shackelford J, Pagano JS. 2012. Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation. J Virol. 86(22):12251–12261.doi:10.1128/JVI.01407-12.
   PubMed Web of Science ®Google Scholar
• Bentz GL, Whitehurst CB, Pagano JS. 2011. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J Virol. 85(19):10144–10153.doi:10.1128/JVI.05035-11.
   PubMed Web of Science ®Google Scholar
• Beyer AR, Truchan HK, May LJ, Walker NJ, Borjesson DL, Carlyon JA. 2015. The Anaplasma phagocytophilum effector AmpA hijacks host cell SUMOylation. Cell Microbiol. 17(4):504–519.doi:10.1111/cmi.12380.
   PubMed Web of Science ®Google Scholar
• Bhutta MS, Sausen DG, Gallo ES, Dahari H, Doncel GF, Borenstein R. 2021. Ginkgolic acid inhibits coronavirus strain 229E infection of human epithelial lung cells. Pharmaceuticals (Basel). 14(10):980.doi:10.3390/ph14100980.
   PubMedGoogle Scholar
• Borenstein R, Hanson BA, Markosyan RM, Gallo ES, Narasipura SD, Bhutta M, Shechter O, Lurain NS, Cohen FS, Al-Harthi L, et al. 2020. Ginkgolic acid inhibits fusion of enveloped viruses. Sci Rep. 10(1):4746.doi:10.1038/s41598-020-61700-0.
   PubMed Web of Science ®Google Scholar
• Boulanger M, Chakraborty M, Tempé D, Piechaczyk M, Bossis G. 2021. SUMO and transcriptional regulation: the lessons of large-scale proteomic, modifomic and genomic studies. Molecules. 26(4):828.doi:10.3390/molecules26040828.
   PubMed Web of Science ®Google Scholar
• Brackett CM, Blagg BSJ. 2021. Current status of SUMOylation inhibitors. Curr Med Chem. 28(20):3892–3912.doi:10.2174/0929867327666200810135039.
   PubMed Web of Science ®Google Scholar
• Cappadocia L, Lima CD. 2018. Ubiquitin-like protein conjugation: structures, chemistry, and mechanism. Chem Rev. 118(3):889–918.doi:10.1021/acs.chemrev.6b00737.
   PubMed Web of Science ®Google Scholar
• Celen AB, Sahin U. 2020. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J. 287(15):3110–3140.doi:10.1111/febs.15319.
   PubMed Web of Science ®Google Scholar
• Celoria V, Rosset F, Pala V, Dapavo P, Ribero S, Quaglino P, Mastorino L. 2023. The skin microbiome and its role in psoriasis: a review. Psoriasis (Auckl). 13:71–78.doi:10.2147/PTT.S328439.
   PubMed Web of Science ®Google Scholar
• Chang HM, Yeh ETH. 2020. SUMO: from bench to bedside. Physiol Rev. 100(4):1599–1619.doi:10.1152/physrev.00025.2019.
   PubMed Web of Science ®Google Scholar
• Chen B, Cao J, Liu W, Zhang Y, Liu Y, Wang M, Xiao F, Ma J, Wang J, Zhang X. 2023. Disturbed gut virome with potent interferonogenic property in systemic lupus erythematosus. Sci Bull (Beijing). 68(3):295–304.doi:10.1016/j.scib.2023.01.021.
   PubMed Web of Science ®Google Scholar
• Chen Y, Li Y, Dai RS, Savage JC, Shinde U, Klimek J, David LL, Young EA, Hafner M, Sears RC, et al. 2023. The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing. Nucleic Acids Res. 51(8):3934–3949.,.doi:10.1093/nar/gkad140.
   PubMed Web of Science ®Google Scholar
• Chen J, Li G, He H, Li X, Niu W, Cao D, Shen A. 2021. Sumoylation of the carboxy-terminal of human cytomegalovirus DNA polymerase processivity factor UL44 attenuates viral DNA replication. Front Microbiol. 12:652719.doi:10.3389/fmicb.2021.652719.
   PubMed Web of Science ®Google Scholar
• Chen K, Liu J, Cao X. 2017. Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review. J Autoimmun. 83:1–11.doi:10.1016/j.jaut.2017.03.008.
   PubMed Web of Science ®Google Scholar
• Chen DD, Shi Q, Liu X, Liang DL, Wu YZ, Fan Q, Xiao K, Chen C, Dong XP. 2023. Aberrant SENP1-SUMO-Sirt3 signaling causes the disturbances of mitochondrial deacetylation and oxidative phosphorylation in prion-infected animal and cell models. ACS Chem Neurosci. 14(9):1610–1621.doi:10.1021/acschemneuro.2c00786.
   PubMed Web of Science ®Google Scholar
• Cho SJ, Yun SM, Jo C, Lee DH, Choi KJ, Song JC, Park SI, Kim YJ, Koh YH. 2015. SUMO1 promotes Abeta production via the modulation of autophagy. Autophagy. 11(1):100–112.doi:10.4161/15548627.2014.984283.
   PubMed Web of Science ®Google Scholar
• Choi GW, Lee Y, Yun M, Kang J, Lee SB. 2020. Formation of SUMO3-conjugated chains of MAVS induced by poly(dA:dT), a ligand of RIG-I, enhances the aggregation of MAVS that drives the secretion of interferon-beta in human keratinocytes. Biochem Biophys Res Commun. 522(4):939–944.doi:10.1016/j.bbrc.2019.11.189.
   PubMed Web of Science ®Google Scholar
• Coleman KE, Huang TT. 2016. How SUMOylation fine-tunes the fanconi anemia DNA repair pathway. Front Genet. 7:61.doi:10.3389/fgene.2016.00061.
   PubMed Web of Science ®Google Scholar
• Conde JN, Schutt WR, Mladinich M, Sohn SY, Hearing P, Mackow ER. 2020. NS5 sumoylation directs nuclear responses that permit zika virus to persistently infect human brain microvascular endothelial cells. J Virol. 94(19):e01086-20.doi:10.1128/JVI.01086-20.
   PubMed Web of Science ®Google Scholar
• Cossec J-C, Traboulsi T, Sart S, Loe-Mie Y, Guthmann M, Hendriks IA, Theurillat I, Nielsen ML, Torres-Padilla M-E, Baroud CN, et al. 2023. Transient suppression of SUMOylation in embryonic stem cells generates embryo-like structures. Cell Rep. 42(4):112380.doi:10.1016/j.celrep.2023.112380.
   PubMed Web of Science ®Google Scholar
• Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, Sauvanet P, Darcha C, Déchelotte P, Bonnet M, et al. 2014. Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut. 63(12):1932–1942.doi:10.1136/gutjnl-2013-305257.
   PubMed Web of Science ®Google Scholar
• Cui Y, Yu H, Zheng X, Peng R, Wang Q, Zhou Y, Wang R, Wang J, Qu B, Shen N, et al. 2017. SENP7 potentiates cGAS activation by relieving SUMO-mediated inhibition of cytosolic DNA sensing. PLoS Pathog. 13(1):e1006156.doi:10.1371/journal.ppat.1006156.
   PubMed Web of Science ®Google Scholar
• Dai YH, Hung LY, Chen RY, Lai CH, Chang KC. 2016. ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex. Transl Res. 175:129–143.e13.doi:10.1016/j.trsl.2016.04.001.
   PubMed Web of Science ®Google Scholar
• Dai T, Zhang L, Ran Y, Zhang M, Yang B, Lu H, Lin S, Zhang L, Zhou F. 2023. MAVS deSUMOylation by SENP1 inhibits its aggregation and antagonizes IRF3 activation. Nat Struct Mol Biol. 30(6):785–799.doi:10.1038/s41594-023-00988-8.
   PubMed Web of Science ®Google Scholar
• Dang R, Rodgers VGJ, García-Sastre A, Liao J. 2022. Human SUMOylation pathway is critical for influenza B virus. Viruses. 14(2):314.doi:10.3390/v14020314.
   PubMed Web of Science ®Google Scholar
• De La Cruz-Herrera CF, Tatham MH, Siddiqi UZ, Shire K, Marcon E, Greenblatt JF, Hay RT, Frappier L. 2023. Changes in SUMO-modified proteins in Epstein-Barr virus infection identifies reciprocal regulation of TRIM24/28/33 complexes and the lytic switch BZLF1. PLoS Pathog. 19(7):e1011477.doi:10.1371/journal.ppat.1011477.
   PubMed Web of Science ®Google Scholar
• Decque A, Joffre O, Magalhaes JG, Cossec J-C, Blecher-Gonen R, Lapaquette P, Silvin A, Manel N, Joubert P-E, Seeler J-S, et al. 2016. Sumoylation coordinates the repression of inflammatory and anti-viral gene-expression programs during innate sensing. Nat Immunol. 17(2):140–149.doi:10.1038/ni.3342.
   PubMed Web of Science ®Google Scholar
• Dehnavi S, Sadeghi M, Johnston TP, Barreto G, Shohan M, Sahebkar A. 2019. The role of protein SUMOylation in rheumatoid arthritis. J Autoimmun. 102:1–7.doi:10.1016/j.jaut.2019.05.006.
   PubMed Web of Science ®Google Scholar
• Demel UM, Böger M, Yousefian S, Grunert C, Zhang L, Hotz PW, Gottschlich A, Köse H, Isaakidis K, Vonficht D, et al. 2022. Activated SUMOylation restricts MHC class I antigen presentation to confer immune evasion in cancer. J Clin Invest. 132(9):e152383.doi:10.1172/jci152383.
   PubMed Web of Science ®Google Scholar
• Di Bacco A, Gill G. 2006. SUMO-specific proteases and the cell cycle. An essential role for SENP5 in cell proliferation. Cell Cycle. 5(20):2310–2313.doi:10.4161/cc.5.20.3367.
   PubMed Web of Science ®Google Scholar
• Díaz-Hernández M, Javier-Reyna R, Sotto-Ortega I, García-Rivera G, Montaño S, Betanzos A, Zanatta D, Orozco E. 2021. Protein sumoylation is crucial for phagocytosis in Entamoeba histolytica trophozoites. Int J Mol Sci. 22(11):5709.doi:10.3390/ijms22115709.
   PubMed Web of Science ®Google Scholar
• Ding Y, Ding Z, Xu J, Li Y, Chen M. 2022. Pharmacological activities of ginkgolic acids in relation to autophagy. Pharmaceuticals (Basel). 15(12):1469.doi:10.3390/ph15121469.
   PubMedGoogle Scholar
• Ding X, Wang A, Ma X, Demarque M, Jin W, Xin H, Dejean A, Dong C. 2016. Protein SUMOylation is required for regulatory T cell expansion and function. Cell Rep. 16(4):1055–1066.doi:10.1016/j.celrep.2016.06.056.
   PubMed Web of Science ®Google Scholar
• Dohlman AB, Arguijo Mendoza D, Ding S, Gao M, Dressman H, Iliev ID, Lipkin SM, Shen X. 2021. The cancer microbiome atlas: a pan-cancer comparative analysis to distinguish tissue-resident microbiota from contaminants. Cell Host Microbe. 29(2):281–298.e5.doi:10.1016/j.chom.2020.12.001.
   PubMed Web of Science ®Google Scholar
• Domingues P, Golebiowski F, Tatham MH, Lopes AM, Taggart A, Hay RT, Hale BG. 2015. Global reprogramming of host SUMOylation during influenza virus infection. Cell Rep. 13(7):1467–1480.doi:10.1016/j.celrep.2015.10.001.
   PubMed Web of Science ®Google Scholar
• Duan H, Zhang X, Figeys D. 2023. An emerging field: post-translational modification in microbiome. Proteomics. 23(3–4):e2100389.doi:10.1002/pmic.202100389.
   PubMed Web of Science ®Google Scholar
• Du L, Liu W, Pichiorri F, Rosen ST. 2022. SUMOylation inhibition enhances multiple myeloma sensitivity to lenalidomide. Cancer Gene Ther. 30(4):567–574.doi:10.1038/s41417-022-00450-9.
   PubMed Web of Science ®Google Scholar
• Du L, Liu W, Rosen ST, Chen Y. 2023. Mechanism of SUMOylation-mediated regulation of type I IFN expression. J Mol Biol. 435(5):167968.doi:10.1016/j.jmb.2023.167968.
   PubMed Web of Science ®Google Scholar
• Dunphy PS, Luo T, McBride JW. 2014. Ehrlichia chaffeensis exploits host SUMOylation pathways to mediate effector-host interactions and promote intracellular survival. Infect Immun. 82(10):4154–4168.doi:10.1128/IAI.01984-14.
   PubMed Web of Science ®Google Scholar
• Eifler K, Vertegaal ACO. 2015. SUMOylation-mediated regulation of cell cycle progression and cancer. Trends Biochem Sci. 40(12):779–793.doi:10.1016/j.tibs.2015.09.006.
   PubMed Web of Science ®Google Scholar
• El Asmi F, Maroui MA, Dutrieux J, Blondel D, Nisole S, Chelbi-Alix MK. 2014. Implication of PMLIV in both intrinsic and innate immunity. PLoS Pathog. 10(2):e1003975.doi:10.1371/journal.ppat.1003975.
   PubMed Web of Science ®Google Scholar
• El-Asmi F, McManus FP, Brantis-de-Carvalho CE, Valle-Casuso JC, Thibault P, Chelbi-Alix MK. 2020. Cross-talk between SUMOylation and ISGylation in response to interferon. Cytokine. 129:155025.doi:10.1016/j.cyto.2020.155025.
   PubMed Web of Science ®Google Scholar
• Everett RD, Rechter S, Papior P, Tavalai N, Stamminger T, Orr A. 2006. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J Virol. 80(16):7995–8005.doi:10.1128/JVI.00734-06.
   PubMed Web of Science ®Google Scholar
• Fiedler M, Ip WH, Hofmann-Sieber H, Wilkens B, Nkrumah FK, Zhang W, Ehrhardt A, Bertzbach LD, Dobner T. 2022. Protein-protein interactions facilitate E4orf6-dependent regulation of E1B-55K SUMOylation in HAdV-C5 infection. Viruses. 14(3):463.doi:10.3390/v14030463.
   PubMed Web of Science ®Google Scholar
• Finkbeiner E, Haindl M, Raman N, Muller S. 2011. SUMO routes ribosome maturation. Nucleus. 2(6):527–532.doi:10.4161/nucl.2.6.17604.
   PubMed Web of Science ®Google Scholar
• Flotho A, Melchior F. 2013. Sumoylation: a regulatory protein modification in health and disease. Annu Rev Biochem. 82(1):357–385.doi:10.1146/annurev-biochem-061909-093311.
   PubMedGoogle Scholar
• Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H, Kimura K, Sodeoka M, Yoshida M. 2009. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol. 16(2):133–140.doi:10.1016/j.chembiol.2009.01.009.
   PubMedGoogle Scholar
• Fukuda I, Ito A, Uramoto M, Saitoh H, Kawasaki H, Osada H, Yoshida M. 2009. Kerriamycin B inhibits protein SUMOylation. J Antibiot (Tokyo). 62(4):221–224.doi:10.1038/ja.2009.10.
   PubMed Web of Science ®Google Scholar
• Garaude J, Farrás R, Bossis G, Charni S, Piechaczyk M, Hipskind RA, Villalba M. 2008. SUMOylation regulates the transcriptional activity of JunB in T lymphocytes. J Immunol. 180(9):5983–5990.doi:10.4049/jimmunol.180.9.5983.
   PubMed Web of Science ®Google Scholar
• Garcia P, Harrod A, Jha S, Jenkins J, Barnhill A, Lee H, Thompson M, Williams JP, Barefield J, Mckinnon A, et al. 2021. Effects of targeting sumoylation processes during latent and induced Epstein-Barr virus infections using the small molecule inhibitor ML-792. Antiviral Res. 188:105038.doi:10.1016/j.antiviral.2021.105038.
   PubMed Web of Science ®Google Scholar
• Gareau JR, Lima CD. 2010. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 11(12):861–871.doi:10.1038/nrm3011.
   PubMed Web of Science ®Google Scholar
• GBD 2019 Antimicrobial Resistance Collaborators. 2022. Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 400(10369):2221–2248.doi:10.1016/s0140-6736(22)02185-7.
   PubMed Web of Science ®Google Scholar
• Geiss-Friedlander R, Melchior F. 2007. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 8(12):947–956.doi:10.1038/nrm2293.
   PubMed Web of Science ®Google Scholar
• Göttig L, Weiß C, Stubbe M, Hanrieder L, Hofmann S, Grodziecki A, Stadler D, Carpentier A, Protzer U, Schreiner S. 2023. Apobec3A deamination functions are involved in antagonizing efficient human adenovirus replication and gene expression. mBio. 14(3):e0347822.doi:10.1128/mbio.03478-22.
   PubMed Web of Science ®Google Scholar
• Gu Z, Chen X, Yang W, Qi Y, Yu H, Wang X, Gong Y, Chen Q, Zhong B, Dai L, et al. 2021. The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response. Cell Mol Immunol. 18(8):1981–1994.doi:10.1038/s41423-020-00564-w.
   PubMed Web of Science ®Google Scholar
• Gujjula R, Veeraiah S, Kumar K, Thakur SS, Mishra K, Kaur R. 2016. Identification of components of the SUMOylation machinery in Candida glabrata: role of the desumoylation peptidase CgUlp2 in virulence. J Biol Chem. 291(37):19573–19589.doi:10.1074/jbc.M115.706044.
   PubMed Web of Science ®Google Scholar
• Guo J, Chen J, Li Y, Li Y, Deng G, Shi J, Liu L, Chen H, Li X. 2022. SUMOylation of matrix protein M1 and filamentous morphology collectively contribute to the replication and virulence of highly pathogenic H5N1 avian influenza viruses in mammals. J Virol. 96(4):e0163021.doi:10.1128/jvi.01630-21.
   PubMed Web of Science ®Google Scholar
• Gupta MK, McLendon PM, Gulick J, James J, Khalili K, Robbins J. 2016. UBC9-mediated sumoylation favorably impacts cardiac function in compromised hearts. Circ Res. 118(12):1894–1905.doi:10.1161/CIRCRESAHA.115.308268.
   PubMed Web of Science ®Google Scholar
• Gu X, Schafer NP, Bueno C, Lu W, Wolynes PG. 2022. A structural dynamics model for how CPEB3 binding to SUMO2 can regulate translational control in dendritic spines. PLoS Comput Biol. 18(11):e1010657.doi:10.1371/journal.pcbi.1010657.
   PubMed Web of Science ®Google Scholar
• Han ZJ, Feng YH, Gu BH, Li YM, Chen H. 2018. The post-translational modification, SUMOylation, and cancer (Review). Int J Oncol. 52(4):1081–1094.doi:10.3892/ijo.2018.4280.
   PubMed Web of Science ®Google Scholar
• Hannoun Z, Maarifi G, Chelbi-Alix MK. 2016. The implication of SUMO in intrinsic and innate immunity. Cytokine Growth Factor Rev. 29:3–16.doi:10.1016/j.cytogfr.2016.04.003.
   PubMed Web of Science ®Google Scholar
• Hay RT. 2005. SUMO: a history of modification. Mol Cell. 18(1):1–12.doi:10.1016/j.molcel.2005.03.012.
   PubMed Web of Science ®Google Scholar
• He X, Riceberg J, Soucy T, Koenig E, Minissale J, Gallery M, Bernard H, Yang X, Liao H, Rabino C, et al. 2017. Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor. Nat Chem Biol. 13(11):1164–1171.doi:10.1038/nchembio.2463.
   PubMed Web of Science ®Google Scholar
• Hickey CM, Wilson NR, Hochstrasser M. 2012. Function and regulation of SUMO proteases. Nat Rev Mol Cell Biol. 13(12):755–766.doi:10.1038/nrm3478.
   PubMed Web of Science ®Google Scholar
• Hirohama M, Kumar A, Fukuda I, Matsuoka S, Igarashi Y, Saitoh H, Takagi M, Shin-Ya K, Honda K, Kondoh Y, et al. 2013. Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2. ACS Chem Biol. 8(12):2635–2642.doi:10.1021/cb400630z.
   PubMed Web of Science ®Google Scholar
• Hofmann S, Plank V, Groitl P, Skvorc N, Hofmann K, Luther J, Ko C, Zimmerman P, Bruss V, Stadler D, et al. 2023. SUMO modification of hepatitis B virus core mediates nuclear entry, promyelocytic leukemia nuclear body association, and efficient formation of covalently closed circular DNA. Microbiol Spectr. 11(3):e0044623.doi:10.1128/spectrum.00446-23.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Yeh LT, Fu SH, Chien MW, Liu YW, Miaw SC, Chang DM, Sytwu HK. 2018. SUMO-defective c-Maf preferentially transactivates Il21 to exacerbate autoimmune diabetes. J Clin Invest. 128(9):3779–3793.doi:10.1172/jci98786.
   PubMed Web of Science ®Google Scholar
• Hu MM, Yang Q, Xie XQ, Liao CY, Lin H, Liu TT, Yin L, Shu HB. 2016. Sumoylation promotes the stability of the DNA sensor cGAS and the adaptor STING to regulate the kinetics of response to DNA virus. Immunity. 45(3):555–569.doi:10.1016/j.immuni.2016.08.014.
   PubMed Web of Science ®Google Scholar
• Hwang J, Kalejta RF. 2009. Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J Virol. 83(13):6591–6598.doi:10.1128/JVI.02639-08.
   PubMed Web of Science ®Google Scholar
• Imbert F, Leavitt G, Langford D. 2022. SUMOylation and viral infections of the brain. Pathogens. 11(7):818.doi:10.3390/pathogens11070818.
   PubMed Web of Science ®Google Scholar
• Impens F, Radoshevich L, Cossart P, Ribet D. 2014. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli. Proc Natl Acad Sci U S A. 111(34):12432–12437.doi:10.1073/pnas.1413825111.
   PubMed Web of Science ®Google Scholar
• Imperiale MJ, Akusjnärvi G, Leppard KN. 1995. Post-transcriptional control of adenovirus gene expression. Curr Top Microbiol Immunol. 199 (Pt 2):139–171.doi:10.1007/978-3-642-79499-5_6.
   PubMedGoogle Scholar
• Irwan ID, Bogerd HP, Cullen BR. 2022. Epigenetic silencing by the SMC5/6 complex mediates HIV-1 latency. Nat Microbiol. 7(12):2101–2113.doi:10.1038/s41564-022-01264-z.
   PubMed Web of Science ®Google Scholar
• Ishov AM, Sotnikov AG, Negorev D, Vladimirova OV, Neff N, Kamitani T, Yeh ET, Strauss JF, 3rd, Maul GG. 1999. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J Cell Biol. 147(2):221–234.doi:10.1083/jcb.147.2.221.
   PubMed Web of Science ®Google Scholar
• Islam A, Tebbji F, Mallick J, Regan H, Dumeaux V, Omran RP, Whiteway M. 2019. Mms21: a putative SUMO E3 ligase in Candida albicans that negatively regulates invasiveness and filamentation, and is required for the genotoxic and cellular stress response. Genetics. 211(2):579–595.doi:10.1534/genetics.118.301769.
   PubMed Web of Science ®Google Scholar
• Jaber T, Bohl CR, Lewis GL, Wood C, West JT, Jr., Weldon RA.Jr. 2009. Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions. J Virol. 83(20):10448–10459.doi:10.1128/JVI.00237-09.
   PubMed Web of Science ®Google Scholar
• Jalal D, Chalissery J, Hassan AH. 2017. Genome maintenance in Saccharomyces cerevisiae: the role of SUMO and SUMO-targeted ubiquitin ligases. Nucleic Acids Res. 45(5):2242–2261.doi:10.1093/nar/gkw1369.
   PubMed Web of Science ®Google Scholar
• Jansen NS, Vertegaal ACO. 2021. A chain of events: regulating target proteins by SUMO polymers. Trends Biochem Sci. 46(2):113–123.doi:10.1016/j.tibs.2020.09.002.
   PubMed Web of Science ®Google Scholar
• Jin S, He X, Ma L, Zhuang Z, Wang Y, Lin M, Cai S, Wei L, Wang Z, Zhao Z, et al. 2022. Suppression of ACE2 SUMOylation protects against SARS-CoV-2 infection through TOLLIP-mediated selective autophagy. Nat Commun. 13(1):5204.doi:10.1038/s41467-022-32957-y.
   PubMed Web of Science ®Google Scholar
• Jovanovic M, Rooney MS, Mertins P, Przybylski D, Chevrier N, Satija R, Rodriguez EH, Fields AP, Schwartz S, Raychowdhury R, et al. 2015. Immunogenetics. Dynamic profiling of the protein life cycle in response to pathogens. Science. 347(6226):1259038.doi:10.1126/science.1259038.
   PubMed Web of Science ®Google Scholar
• Khoury GA, Baliban RC, Floudas CA. 2011. Proteome-wide post-translational modification statistics: frequency analysis and curation of the Swiss-prot database. Sci Rep. 1(1):90.doi:10.1038/srep00090.
   PubMedGoogle Scholar
• Kiboneka A. 2021. Principals of innate and adaptive immunity. Immunity to microbes & fundamental concepts in immunology. World J Adv Res Rev. 10(3):188–197.doi:10.30574/wjarr.2021.10.3.0271.
   Google Scholar
• Kim YS, Keyser SG, Schneekloth JS.Jr. 2014. Synthesis of 2’,3’,4’-trihydroxyflavone (2-D08), an inhibitor of protein sumoylation. Bioorg Med Chem Lett. 24(4):1094–1097.doi:10.1016/j.bmcl.2014.01.010.
   PubMed Web of Science ®Google Scholar
• Kim ET, Kim YE, Kim YJ, Lee MK, Hayward GS, Ahn JH. 2014. Analysis of human cytomegalovirus-encoded SUMO targets and temporal regulation of SUMOylation of the immediate-early proteins IE1 and IE2 during infection. PLoS One. 9(7):e103308.doi:10.1371/journal.pone.0103308.
   PubMed Web of Science ®Google Scholar
• Kukkula A, Ojala VK, Mendez LM, Sistonen L, Elenius K, Sundvall M. 2021. Therapeutic potential of targeting the SUMO pathway in cancer. Cancers (Basel). 13(17):4402.doi:10.3390/cancers13174402.
   PubMed Web of Science ®Google Scholar
• Kumar S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, Sluijter M, Ruano D, González-Prieto R, Verlaan-de Vries M, Rip J, Arens R, et al. 2022. Targeting pancreatic cancer by TAK-981: a SUMOylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut. 71(11):2266–2283.doi:10.1136/gutjnl-2021-324834.
   PubMed Web of Science ®Google Scholar
• Kumar R, Theiss AL, Venuprasad K. 2021. RORγt protein modifications and IL-17-mediated inflammation. Trends Immunol. 42(11):1037–1050.doi:10.1016/j.it.2021.09.005.
   PubMed Web of Science ®Google Scholar
• Kunz K, Piller T, Müller S. 2018. SUMO-specific proteases and isopeptidases of the SENP family at a glance. J Cell Sci. 131(6):jcs211904.doi:10.1242/jcs.211904.
   PubMed Web of Science ®Google Scholar
• Kurahashi S, Hayakawa F, Miyata Y, Yasuda T, Minami Y, Tsuzuki S, Abe A, Naoe T. 2011. PAX5-PML acts as a dual dominant-negative form of both PAX5 and PML. Oncogene. 30(15):1822–1830.doi:10.1038/onc.2010.554.
   PubMed Web of Science ®Google Scholar
• Kusiak A, Brady G. 2022. Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation. Biochem Pharmacol. 205:115246.doi:10.1016/j.bcp.2022.115246.
   PubMed Web of Science ®Google Scholar
• Landau LM, Kagan JC. 2023. Beyond natural biology: rewiring cellular networks to study innate immunity. Curr Opin Immunol. 83:102349.doi:10.1016/j.coi.2023.102349.
   PubMed Web of Science ®Google Scholar
• Lapaquette P, Fritah S, Lhocine N, Andrieux A, Nigro G, Mounier J, Sansonetti P, Dejean A. 2017. Shigella entry unveils a calcium/calpain-dependent mechanism for inhibiting sumoylation. Elife. 6:e27444.doi:10.7554/eLife.27444.
   PubMed Web of Science ®Google Scholar
• Leach MD, Stead DA, Argo E, Brown AJ. 2011. Identification of sumoylation targets, combined with inactivation of SMT3, reveals the impact of sumoylation upon growth, morphology, and stress resistance in the pathogen Candida albicans. Mol Biol Cell. 22(5):687–702.doi:10.1091/mbc.E10-07-0632.
   PubMed Web of Science ®Google Scholar
• Liang JX, Gao W, Zeng XW, Cheng GP, Cai L, Tao KY, Yang X. 2020. SUMO4 small interfering RNA attenuates invasion and migration via the JAK2/STAT3 pathway in non-small cell lung cancer cells. Oncol Lett. 20(5):225.doi:10.3892/ol.2020.12088.
   PubMed Web of Science ®Google Scholar
• Liang YC, Lee CC, Yao YL, Lai CC, Schmitz ML, Yang WM. 2016. SUMO5, a novel poly-SUMO isoform, regulates PML nuclear bodies. Sci Rep. 6(1):26509.doi:10.1038/srep26509.
   PubMedGoogle Scholar
• Liberman AC, Druker J, Garcia FA, Holsboer F, Arzt E. 2009. Intracellular molecular signaling. Basis for specificity to glucocorticoid anti-inflammatory actions. Ann N Y Acad Sci. 1153(1):6–13.doi:10.1111/j.1749-6632.2008.03958.x.
   PubMedGoogle Scholar
• Li YY, Cen H, Gong BN, Mai S, Wang QL, Mou S, Li Y. 2021. TCR-induced tyrosine phosphorylation at Tyr270 of SUMO protease SENP1 by Lck modulates SENP1 enzyme activity and specificity. Front Cell Dev Biol. 9:789348.doi:10.3389/fcell.2021.789348.
   PubMed Web of Science ®Google Scholar
• Lightcap ES, Yu P, Grossman S, Song K, Khattar M, Xega K, He X, Gavin JM, Imaichi H, Garnsey JJ, et al. 2021. A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models. Sci Transl Med. 13(611):eaba7791.doi:10.1126/scitranslmed.aba7791.
   PubMed Web of Science ®Google Scholar
• Lima CD, Reverter D. 2008. Structure of the human SENP7 catalytic domain and poly-SUMO deconjugation activities for SENP6 and SENP7. J Biol Chem. 283(46):32045–32055.doi:10.1074/jbc.M805655200.
   PubMed Web of Science ®Google Scholar
• Li W, Qiao J, You Q, Zong S, Peng Q, Liu Y, Hu S, Liu W, Li S, Shu X, et al. 2021. SARS-CoV-2 Nsp5 activates NF-kappaB pathway by upregulating SUMOylation of MAVS. Front Immunol. 12:750969.doi:10.3389/fimmu.2021.750969.
   PubMed Web of Science ®Google Scholar
• Liu X, Chen W, Wang Q, Li L, Wang C. 2013. Negative regulation of TLR inflammatory signaling by the SUMO-deconjugating enzyme SENP6. PLoS Pathog. 9(6):e1003480.doi:10.1371/journal.ppat.1003480.
   PubMed Web of Science ®Google Scholar
• Liu K, Guo C, Lao Y, Yang J, Chen F, Zhao Y, Yang Y, Yang J, Yi J. 2020. A fine-tuning mechanism underlying self-control for autophagy: deSUMOylation of BECN1 by SENP3. Autophagy. 16(6):975–990.doi:10.1080/15548627.2019.1647944.
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu C, Wang X, Li W, Zhou J, Dong P, Xiao MZX, Wang C, Zhang Y, Fu J, et al. 2021. RSK1 SUMOylation is required for KSHV lytic replication. PLoS Pathog. 17(12):e1010123.doi:10.1371/journal.ppat.1010123.
   PubMed Web of Science ®Google Scholar
• Liu B, Mink S, Wong KA, Stein N, Getman C, Dempsey PW, Wu H, Shuai K. 2004. PIAS1 selectively inhibits interferon-inducible genes and is important in innate immunity. Nat Immunol. 5(9):891–898.doi:10.1038/ni1104.
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang X, Liu C, Deng H, Li W, Wang X, Xu X, Xiao MZX, Wang C, Zhang Y, et al. 2022. The SUMO E3 ligase activity of ORF45 determines KSHV lytic replication. PLoS Pathog. 18(4):e1010504.doi:10.1371/journal.ppat.1010504.
   PubMedGoogle Scholar
• Liu X, Zhang S, Dong Y, Xie Y, Li Q. 2023. SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-kappaB pathway. Exp Cell Res. 433(2):113822.doi:10.1016/j.yexcr.2023.113822.
   PubMed Web of Science ®Google Scholar
• Li R, Wang L, Liao G, Guzzo CM, Matunis MJ, Zhu H, Hayward SD. 2012. SUMO binding by the Epstein-Barr virus protein kinase BGLF4 is crucial for BGLF4 function. J Virol. 86(10):5412–5421.doi:10.1128/jvi.00314-12.
   PubMed Web of Science ®Google Scholar
• Li L, Wen J, Tuo QH, Liao DF. 2013. Effects of SUMOylation on the subcellular localization and function of DAXX. Sheng Li Xue Bao. 65(1):89–95.
   PubMedGoogle Scholar
• Lu Y, Zhou Q, Shi Y, Liu J, Zhong F, Hao X, Li C, Chen N, Wang W. 2013. SUMOylation of PPARγ by rosiglitazone prevents LPS-induced NCoR degradation mediating down regulation of chemokines expression in renal proximal tubular cells. PLoS One. 8(11):e79815.doi:10.1371/journal.pone.0079815.
   PubMed Web of Science ®Google Scholar
• Lyman M, Forsberg K, Sexton DJ, Chow NA, Lockhart SR, Jackson BR, Chiller T. 2023. Worsening spread of Candida auris in the United States, 2019 to 2021. Ann Intern Med. 176(4):489–495.doi:10.7326/m22-3469.
   PubMed Web of Science ®Google Scholar
• Maarifi G, Fernandez J, Portilho DM, Boulay A, Dutrieux J, Oddos S, Butler-Browne G, Nisole S, Arhel NJ. 2018. RanBP2 regulates the anti-retroviral activity of TRIM5α by SUMOylation at a predicted phosphorylated SUMOylation motif. Commun Biol. 1(1):193.doi:10.1038/s42003-018-0198-0.
   PubMedGoogle Scholar
• Madahar V, Dang R, Zhang Q, Liu C, Rodgers VGJ, Liao J. 2023. Human post-translational SUMOylation modification of SARS-CoV-2 nucleocapsid protein enhances its interaction affinity with itself and plays a critical role in its nuclear translocation. Viruses. 15(7):1600.doi:10.3390/v15071600.
   PubMed Web of Science ®Google Scholar
• Maeda A, Lee BH, Yoshimatsu K, Saijo M, Kurane I, Arikawa J, Morikawa S. 2003. The intracellular association of the nucleocapsid protein (NP) of hantaan virus (HTNV) with small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9). Virology. 305(2):288–297.doi:10.1006/viro.2002.1767.
   PubMed Web of Science ®Google Scholar
• Mak TW, Saunders ME. 2006. Immunity to pathogens. Immune Response. 2006:641–694.
   Google Scholar
• Maruthi M, Singh D, Reddy SR, Mastan BS, Mishra S, Kumar KA. 2017. Modulation of host cell SUMOylation facilitates efficient development of Plasmodium berghei and Toxoplasma gondii. Cell Microbiol. 19(7):e12723.doi:10.1111/cmi.12723.
   Web of Science ®Google Scholar
• Mayer FL, Sánchez-León E, Kronstad JW. 2018. A chemical genetic screen reveals a role for proteostasis in capsule and biofilm formation by Cryptococcus neoformans. Microb Cell. 5(11):495–510.doi:10.15698/mic2018.11.656.
   PubMed Web of Science ®Google Scholar
• Mete B, Pekbilir E, Bilge BN, Georgiadou P, Çelik E, Sutlu T, Tabak F, Sahin U. 2022. Human immunodeficiency virus type 1 impairs sumoylation. Life Sci Alliance. 5(6):e202101103.doi:10.26508/lsa.202101103.
   PubMed Web of Science ®Google Scholar
• Mogensen TH. 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev. 22(2):240–273.doi:10.1128/CMR.00046-08.
   PubMed Web of Science ®Google Scholar
• Mohapatra G, Gaur P, Mujagond P, Singh M, Rana S, Pratap S, Kaur N, Verma S, Krishnan V, Singh N, et al. 2019. A SUMOylation-dependent switch of RAB7 governs intracellular life and pathogenesis of Salmonella Typhimurium. J Cell Sci. 132(1):jcs222612.doi:10.1242/jcs.222612.
   PubMed Web of Science ®Google Scholar
• Monribot-Villanueva J, Zurita M, Vázquez M. 2017. Developmental transcriptional regulation by SUMOylation, an evolving field. Genesis. 55(3):e23009.doi:10.1002/dvg.23009.
   Web of Science ®Google Scholar
• Msemburi W, Karlinsky A, Knutson V, Aleshin-Guendel S, Chatterji S, Wakefield J. 2023. The WHO estimates of excess mortality associated with the COVID-19 pandemic. Nature. 613(7942):130–137.doi:10.1038/s41586-022-05522-2.
   PubMed Web of Science ®Google Scholar
• Müller S, Dejean A. 1999. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption. J Virol. 73(6):5137–5143.doi:10.1128/JVI.73.6.5137-5143.1999.
   PubMed Web of Science ®Google Scholar
• Muromoto R, Ishida M, Sugiyama K, Sekine Y, Oritani K, Shimoda K, Matsuda T. 2006. Sumoylation of Daxx regulates IFN-induced growth suppression of B lymphocytes and the hormone receptor-mediated transactivation. J Immunol. 177(2):1160–1170.doi:10.4049/jimmunol.177.2.1160.
   PubMed Web of Science ®Google Scholar
• Naito M, Morton JB, Pawlowska TE. 2015. Minimal genomes of mycoplasma-related endobacteria are plastic and contain host-derived genes for sustained life within Glomeromycota. Proc Natl Acad Sci U S A. 112(25):7791–7796.doi:10.1073/pnas.1501676112.
   PubMed Web of Science ®Google Scholar
• Nakamura A, Grossman S, Song K, Xega K, Zhang Y, Cvet D, Berger A, Shapiro G, Huszar D. 2022. The SUMOylation inhibitor subasumstat potentiates rituximab activity by IFN1-dependent macrophage and NK cell stimulation. Blood. 139(18):2770–2781.doi:10.1182/blood.2021014267.
   PubMed Web of Science ®Google Scholar
• Nayak A, Müller S. 2014. SUMO-specific proteases/isopeptidases: SENPs and beyond. Genome Biol. 15(7):422.doi:10.1186/s13059-014-0422-2.
   PubMed Web of Science ®Google Scholar
• Netea MG, Schlitzer A, Placek K, Joosten LAB, Schultze JL. 2019. Innate and adaptive immune memory: an evolutionary continuum in the host’s response to pathogens. Cell Host Microbe. 25(1):13–26.doi:10.1016/j.chom.2018.12.006.
   PubMed Web of Science ®Google Scholar
• Nie XY, Xue Y, Li L, Jiang Z, Qin B, Wang Y, Wang S. 2023. A functional intact SUMOylation machinery in Aspergillus flavus contributes to fungal and aflatoxin contamination of food. Int J Food Microbiol. 398:110241.doi:10.1016/j.ijfoodmicro.2023.110241.
   PubMed Web of Science ®Google Scholar
• Nie X, Yu S, Qiu M, Wang X, Wang Y, Bai Y, Zhang F, Wang S. 2016. Aspergillus flavus SUMO contributes to fungal virulence and toxin attributes. J Agric Food Chem. 64(35):6772–6782.doi:10.1021/acs.jafc.6b02199.
   PubMed Web of Science ®Google Scholar
• Okuda K, Silva Costa Franco MM, Yasunaga A, Gazzinelli R, Rabinovitch M, Cherry S, Silverman N. 2022. Leishmania amazonensis sabotages host cell SUMOylation for intracellular survival. iScience. 25(9):104909.doi:10.1016/j.isci.2022.104909.
   PubMed Web of Science ®Google Scholar
• Olsen SK, Capili AD, Lu X, Tan DS, Lima CD. 2010. Active site remodelling accompanies thioester bond formation in the SUMO E1. Nature. 463(7283):906–912.doi:10.1038/nature08765.
   PubMed Web of Science ®Google Scholar
• Owerbach D, McKay EM, Yeh ET, Gabbay KH, Bohren KM. 2005. A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation. Biochem Biophys Res Commun. 337(2):517–520.doi:10.1016/j.bbrc.2005.09.090.
   PubMed Web of Science ®Google Scholar
• Pan Y, Lei X, Zhang Y. 2022. Association predictions of genomics, proteinomics, transcriptomics, microbiome, metabolomics, pathomics, radiomics, drug, symptoms, environment factor, and disease networks: a comprehensive approach. Med Res Rev. 42(1):441–461.doi:10.1002/med.21847.
   PubMed Web of Science ®Google Scholar
• Pennella MA, Liu Y, Woo JL, Kim CA, Berk AJ. 2010. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J Virol. 84(23):12210–12225.doi:10.1128/jvi.01442-10.
   PubMed Web of Science ®Google Scholar
• Perusina Lanfranca M, van Loben Sels JM, Ly CY, Grams TR, Dhummakupt A, Bloom DC, Davido DJ. 2022. A 77 amino acid region in the N-terminal half of the HSV-1 E3 ubiquitin ligase ICP0 contributes to counteracting an established type 1 interferon response. Microbiol Spectr. 10(4):e0059322.doi:10.1128/spectrum.00593-22.
   PubMed Web of Science ®Google Scholar
• Péter C, Nagy F, Viczián A. 2021. SUMOylation of different targets fine-tunes phytochrome signaling. New Phytol. 232(3):1201–1211.doi:10.1111/nph.17634.
   PubMed Web of Science ®Google Scholar
• Ponce-Cusi R, Bravo L, Paez KJ, Pinto JA, Pilco-Ferreto N. 2024. Host-pathogen interaction: biology and public health. Methods Mol Biol. 2751:3–18.doi:10.1007/978-1-0716-3617-6_1.
   PubMedGoogle Scholar
• Ponder EL, Albrow VE, Leader BA, Békés M, Mikolajczyk J, Fonović UP, Shen A, Drag M, Xiao J, Deu E, et al. 2011. Functional characterization of a SUMO deconjugating protease of Plasmodium falciparum using newly identified small molecule inhibitors. Chem Biol. 18(6):711–721.doi:10.1016/j.chembiol.2011.04.010.
   PubMedGoogle Scholar
• Portilho DM, Fernandez J, Ringeard M, Machado AK, Boulay A, Mayer M, Müller-Trutwin M, Beignon A-S, Kirchhoff F, Nisole S, et al. 2016. Endogenous TRIM5alpha function is regulated by SUMOylation and nuclear sequestration for efficient innate sensing in dendritic cells. Cell Rep. 14(2):355–369.doi:10.1016/j.celrep.2015.12.039.
   PubMed Web of Science ®Google Scholar
• Retanal C, Ball B, Geddes-McAlister J. 2021. Post-translational modifications drive success and failure of fungal-host interactions. J Fungi (Basel). 7(2):124.doi:10.3390/jof7020124.
   PubMedGoogle Scholar
• Ribet D, Hamon M, Gouin E, Nahori MA, Impens F, Neyret-Kahn H, Gevaert K, Vandekerckhove J, Dejean A, Cossart P. 2010. Listeria monocytogenes impairs SUMOylation for efficient infection. Nature. 464(7292):1192–1195.doi:10.1038/nature08963.
   PubMed Web of Science ®Google Scholar
• Rodríguez JA. 2014. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins. Semin Cancer Biol. 27:11–19.doi:10.1016/j.semcancer.2014.03.005.
   PubMed Web of Science ®Google Scholar
• Rosonina E, Akhter A, Dou Y, Babu J, Sri Theivakadadcham VS. 2017. Regulation of transcription factors by sumoylation. Transcription. 8(4):220–231.doi:10.1080/21541264.2017.1311829.
   PubMed Web of Science ®Google Scholar
• Ryu HY. 2022. SUMO pathway is required for ribosome biogenesis. BMB Rep. 55(11):535–540.doi:10.5483/BMBRep.2022.55.11.130.
   PubMed Web of Science ®Google Scholar
• Ryu HY, Hochstrasser M. 2021. Histone sumoylation and chromatin dynamics. Nucleic Acids Res. 49(11):6043–6052.doi:10.1093/nar/gkab280.
   PubMed Web of Science ®Google Scholar
• Ryu HY, Zhao D, Li J, Su D, Hochstrasser M. 2020. Histone sumoylation promotes Set3 histone-deacetylase complex-mediated transcriptional regulation. Nucleic Acids Res. 48(21):12151–12168.doi:10.1093/nar/gkaa1093.
   PubMed Web of Science ®Google Scholar
• Sahin U, Ferhi O, Carnec X, Zamborlini A, Peres L, Jollivet F, Vitaliano-Prunier A, de Thé H, Lallemand-Breitenbach V. 2014. Interferon controls SUMO availability via the Lin28 and let-7 axis to impede virus replication. Nat Commun. 5(1):4187.doi:10.1038/ncomms5187.
   PubMedGoogle Scholar
• Sahu MS, Patra S, Kumar K, Kaur R. 2020. SUMOylation in human pathogenic fungi: role in physiology and virulence. J Fungi (Basel). 6(1):32.doi:10.3390/jof6010032.
   PubMedGoogle Scholar
• Sajeev TK, Joshi G, Arya P, Mahajan V, Chaturvedi A, Mishra RK. 2021. SUMO and SUMOylation pathway at the forefront of host immune response. Front Cell Dev Biol. 9:681057.doi:10.3389/fcell.2021.681057.
   PubMed Web of Science ®Google Scholar
• Salahuddin S, Fath EK, Biel N, Ray A, Moss CR, Patel A, Patel S, Hilding L, Varn M, Ross T, et al. 2019. Epstein-Barr virus latent membrane protein-1 induces the expression of SUMO-1 and SUMO-2/3 in LMP1-positive lymphomas and cells. Sci Rep. 9(1):208.doi:10.1038/s41598-018-36312-4.
   PubMedGoogle Scholar
• Salam MA, Al-Amin MY, Salam MT, Pawar JS, Akhter N, Rabaan AA, Alqumber MAA. 2023. Antimicrobial resistance: a growing serious threat for global public health. Healthcare (Basel). 11(13):1946.doi:10.3390/healthcare11131946.
   PubMedGoogle Scholar
• Sá-Pessoa J, Przybyszewska K, Vasconcelos FN, Dumigan A, Frank CG, Hobley L, Bengoechea JA. 2020. Klebsiella pneumoniae reduces SUMOylation to limit host defense responses. mBio. 11(5):e01733-20.doi:10.1128/mBio.01733-20.
   PubMed Web of Science ®Google Scholar
• Schulz S, Chachami G, Kozaczkiewicz L, Winter U, Stankovic-Valentin N, Haas P, Hofmann K, Urlaub H, Ovaa H, Wittbrodt J, et al. 2012. Ubiquitin-specific protease-like 1 (USPL1) is a SUMO isopeptidase with essential, non-catalytic functions. EMBO Rep. 13(10):930–938.doi:10.1038/embor.2012.125.
   PubMed Web of Science ®Google Scholar
• Selby TL, Biel N, Varn M, Patel S, Patel A, Hilding L, Ray A, Ross T, Cramblet WT, Moss CR, et al. 2019. The Epstein-Barr virus oncoprotein, LMP1, regulates the function of SENP2, a SUMO-protease. Sci Rep. 9(1):9523.doi:10.1038/s41598-019-45825-5.
   PubMedGoogle Scholar
• Sen R, Nayak L, De RK. 2016. A review on host-pathogen interactions: classification and prediction. Eur J Clin Microbiol Infect Dis. 35(10):1581–1599.doi:10.1007/s10096-016-2716-7.
   PubMed Web of Science ®Google Scholar
• Sheban D, Shani T, Maor R, Aguilera-Castrejon A, Mor N, Oldak B, Shmueli MD, Eisenberg-Lerner A, Bayerl J, Hebert J, et al. 2022. SUMOylation of linker histone H1 drives chromatin condensation and restriction of embryonic cell fate identity. Mol Cell. 82(1):106–122.e9.doi:10.1016/j.molcel.2021.11.011.
   PubMed Web of Science ®Google Scholar
• Shen R, Lü D, Chen G, Liu M, Pu S, Zhang Y, Wang Q, Qian P, Tang X. 2022. SUMOylation regulates BmNPV replication by moderating PKIP intracellular localization. Processes. 10(2):261.doi:10.3390/pr10020261.
   Web of Science ®Google Scholar
• Shimshon L, Michaeli A, Hadar R, Nutt SL, David Y, Navon A, Waisman A, Tirosh B. 2011. SUMOylation of Blimp-1 promotes its proteasomal degradation. FEBS Lett. 585(15):2405–2409.doi:10.1016/j.febslet.2011.06.022.
   PubMed Web of Science ®Google Scholar
• Shin EJ, Shin HM, Nam E, Kim WS, Kim JH, Oh BH, Yun Y. 2012. DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep. 13(4):339–346.doi:10.1038/embor.2012.3.
   PubMed Web of Science ®Google Scholar
• Shirinian M, Kfoury Y, Dassouki Z, El-Hajj H, Bazarbachi A. 2013. Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation. Front Microbiol. 4:231.doi:10.3389/fmicb.2013.00231.
   PubMed Web of Science ®Google Scholar
• Sidik SM, Salsman J, Dellaire G, Rohde JR. 2015. Shigella infection interferes with SUMOylation and increases PML-NB number. PLoS One. 10(4):e0122585.doi:10.1371/journal.pone.0122585.
   PubMed Web of Science ®Google Scholar
• Sinigalia E, Alvisi G, Segré CV, Mercorelli B, Muratore G, Winkler M, Hsiao H-H, Urlaub H, Ripalti A, Chiocca S, et al. 2012. The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner. PLoS One. 7(11):e49630.doi:10.1371/journal.pone.0049630.
   PubMed Web of Science ®Google Scholar
• Su J, Richter K, Zhang C, Gu Q, Li L. 2007. Differential regulation of interleukin-1 receptor associated kinase 1 (IRAK1) splice variants. Mol Immunol. 44(5):900–905.doi:10.1016/j.molimm.2006.03.021.
   PubMed Web of Science ®Google Scholar
• Sugiokto FG, Saiada F, Zhang K, Li R. 2024. SUMOylation of the m6A reader YTHDF2 by PIAS1 promotes viral RNA decay to restrict EBV replication. mBio. 15(2):e03168-23.doi:10.1128/mbio.03168-23.
   PubMed Web of Science ®Google Scholar
• Sumam de Oliveira D, Kronenberger T, Palmisano G, Wrenger C, de Souza EE. 2021. Targeting SUMOylation in Plasmodium as a potential target for malaria therapy. Front Cell Infect Microbiol. 11:685866.doi:10.3389/fcimb.2021.685866.
   PubMed Web of Science ®Google Scholar
• Sun W, Gao C, Hartana CA, Osborn MR, Einkauf KB, Lian X, Bone B, Bonheur N, Chun T-W, Rosenberg ES, et al. 2023. Phenotypic signatures of immune selection in HIV-1 reservoir cells. Nature. 614(7947):309–317.doi:10.1038/s41586-022-05538-8.
   PubMed Web of Science ®Google Scholar
• Sun L, Kong H, Yu M, Zhang Z, Zhang H, Na L, Qu Y, Zhang Y, Chen H, Wang X. 2023. The SUMO-interacting motif in NS2 promotes adaptation of avian influenza virus to mammals. Sci Adv. 9(28):eadg5175.doi:10.1126/sciadv.adg5175.
   PubMed Web of Science ®Google Scholar
• Tempé D, Vives E, Brockly F, Brooks H, De Rossi S, Piechaczyk M, Bossis G. 2014. SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation. Oncogene. 33(7):921–927.doi:10.1038/onc.2013.4.
   PubMed Web of Science ®Google Scholar
• Tripathi L, Ntui VO, Tripathi JN. 2022. Control of bacterial diseases of banana using CRISPR/Cas-based gene editing. Int J Mol Sci. 23(7):3619.doi:10.3390/ijms23073619.
   PubMed Web of Science ®Google Scholar
• Van Nguyen T, Angkasekwinai P, Dou H, Lin FM, Lu LS, Cheng J, Chin YE, Dong C, Yeh ET. 2012. SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation. Mol Cell. 45(2):210–221.doi:10.1016/j.molcel.2011.12.026.
   PubMed Web of Science ®Google Scholar
• Verma S, Mohapatra G, Ahmad SM, Rana S, Jain S, Khalsa JK, Srikanth CV. 2015. Salmonella engages host microRNAs to modulate SUMOylation: a new arsenal for intracellular survival. Mol Cell Biol. 35(17):2932–2946.doi:10.1128/mcb.00397-15.
   PubMed Web of Science ®Google Scholar
• Vertegaal ACO. 2022. Signalling mechanisms and cellular functions of SUMO. Nat Rev Mol Cell Biol. 23(11):715–731.doi:10.1038/s41580-022-00500-y.
   PubMed Web of Science ®Google Scholar
• Wang G, Zhao Y, Zhou Y, Jiang L, Liang L, Kong F, Yan Y, Wang X, Wang Y, Wen X, et al. 2022. PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence. PLoS Pathog. 18(4):e1010446.doi:10.1371/journal.ppat.1010446.
   PubMed Web of Science ®Google Scholar
• Weger S, Hammer E, Heilbronn R. 2004. SUMO-1 modification regulates the protein stability of the large regulatory protein Rep78 of adeno associated virus type 2 (AAV-2). Virology. 330(1):284–294.doi:10.1016/j.virol.2004.09.028.
   PubMed Web of Science ®Google Scholar
• Wilkinson KA, Henley JM. 2010. Mechanisms, regulation and consequences of protein SUMOylation. Biochem J. 428(2):133–145.doi:10.1042/bj20100158.
   PubMedGoogle Scholar
• Wimmer P, Schreiner S, Dobner T. 2012. Human pathogens and the host cell SUMOylation system. J Virol. 86(2):642–654.doi:10.1128/jvi.06227-11.
   PubMed Web of Science ®Google Scholar
• Won TJ, Lee YJ, Hyung KE, Yang E, Sohn UD, Min HY, Lee DI, Park SY, Hwang KW. 2015. SUMO2 overexpression enhances the generation and function of interleukin-17-producing CD8+ T cells in mice. Cell Signal. 27(6):1246–1252.doi:10.1016/j.cellsig.2015.03.001.
   PubMed Web of Science ®Google Scholar
• Wu L, Pan T, Zhou M, Chen T, Wu S, Lv X, Liu J, Yu F, Guan Y, Liu B, et al. 2022. CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2. EMBO Rep. 23(7):e53855.doi:10.15252/embr.202153855.
   PubMed Web of Science ®Google Scholar
• Xia C, Su J, Liu C, Mai Z, Yin S, Yang C, Fu L. 2023. Human microbiomes in cancer development and therapy. MedComm (2020). 4(2):e221.doi:10.1002/mco2.221.
   PubMedGoogle Scholar
• Xiao N, Li H, Mei W, Cheng J. 2015. SUMOylation attenuates human β-arrestin 2 inhibition of IL-1R/TRAF6 signaling. J Biol Chem. 290(4):1927–1935.doi:10.1074/jbc.M114.608703.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Qureischi M, Dietz L, Vaeth M, Vallabhapurapu SD, Klein-Hessling S, Klein M, Liang C, König A, Serfling E, et al. 2021. Lack of NFATc1 SUMOylation prevents autoimmunity and alloreactivity. J Exp Med. 218(1):e20181853.doi:10.1084/jem.20181853.
   PubMed Web of Science ®Google Scholar
• Yau TY, Sander W, Eidson C, Courey AJ. 2021. SUMO interacting motifs: structure and function. Cells. 10(11):2825.doi:10.3390/cells10112825.
   PubMed Web of Science ®Google Scholar
• Youssouf N, Recasens-Zorzo C, Molle V, Bossis G, Soubeyran P, Gannoun-Zaki L. 2021. Staphylococcus aureus decreases SUMOylation host response to promote intramacrophage survival. Int J Mol Sci. 22(15):8108.doi:10.3390/ijms22158108.
   PubMed Web of Science ®Google Scholar
• Yu F, Wang L, Wang H, Sheng J, Lu L. 2017. Repression of SUMOylation pathway by grass carp reovirus contributes to the upregulation of PKR in an IFN-independent manner. Oncotarget. 8(42):71500–71511.doi:10.18632/oncotarget.20309.
   PubMedGoogle Scholar
• Zhang Z, Xia S, Wang Z, Yin N, Chen J, Shao L. 2023. The SUMOylation of human cytomegalovirus capsid assembly protein precursor (UL80.5) affects its interaction with major capsid protein (UL86) and viral replication. Viruses. 15(4):931.doi:10.3390/v15040931.
   PubMed Web of Science ®Google Scholar
• Zhou Y, He C, Wang L, Ge B. 2017. Post-translational regulation of antiviral innate signaling. Eur J Immunol. 47(9):1414–1426.doi:10.1002/eji.201746959.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Chu H, Wen L, Yuan S, Chik KK-H, Yuen TT-T, Yip CC-Y, Wang D, Zhou J, Yin F, et al. 2019. Targeting SUMO modification of the non-structural protein 5 of zika virus as a host-targeting antiviral strategy. Int J Mol Sci. 20(2):392.doi:10.3390/ijms20020392.
   PubMed Web of Science ®Google Scholar
• Zhu X, Qiu C, Wang Y, Jiang Y, Chen Y, Fan L, Ren R, Wang Y, Chen Y, Feng Y, et al. 2022. FGFR1 SUMOylation coordinates endothelial angiogenic signaling in angiogenesis. Proc Natl Acad Sci U S A. 119(26):e2202631119.doi:10.1073/pnas.2202631119.
   PubMed Web of Science ®Google Scholar
• Zinngrebe J, Montinaro A, Peltzer N, Walczak H. 2014. Ubiquitin in the immune system. EMBO Rep. 15(1):28–45.doi:10.1002/embr.201338025.
   PubMed Web of Science ®Google Scholar
• Zuo Y, Cheng JK. 2009. Small ubiquitin-like modifier protein-specific protease 1 and prostate cancer. Asian J Androl. 11(1):36–38.doi:10.1038/aja.2008.45.
   PubMed Web of Science ®Google Scholar